Myron S. Cohen, MD, has been part of the HIV Prevention Trials Network (HPTN) since its inception. He now serves as Co-Principal Investigator of the Network along with Wafaa El-Sadr, MD, MPH, MPA. Dr. Cohen is recognized as one of the world's leading authorities on the transmission and prevention of HIV/AIDS and other sexually transmitted diseases. He is the principal investigator of HPTN 052, a multinational trial which demonstrated that antiretroviral treatment reduces the sexual transmission of HIV by 96 percent. Considered a "game-changer" in HIV prevention research, HPTN 052 was recognized by Science magazine as the "Breakthrough of the Year" in 2011.
Along with his work at the HPTN, Dr. Cohen is the J. Herbert Bate Distinguished Professor of Medicine, Microbiology and Immunology and Epidemiology at the University of North Carolina (UNC) at Chapel Hill. He also serves as chief of the Division of Infectious Diseases, Director of the Institute for Global Health & Infectious Diseases, and Associate Vice Chancellor for Global Health. In 2008, he received the O. Max Gardner Award, the highest honor in the UNC 16-campus system.
Dr. Cohen began his HIV work in the early 1980s and has spent a large part of his career conducting research in resource-limited countries, most notably China and Malawi. He helped launch UNC Project-Malawi, which collaborates with Malawi Ministry of Health to provide technical assistance in the design of clinical management guidelines for HIV and STDs.
Dr. Cohen received his M.D. degree from Rush Medical College. He is a fellow of the American College of Physicians and the Infectious Disease Society of America and is a member of the American Society of Clinical Investigation and the American Association of Physicians. He was elected to the Institute of Medicine in 2012.